COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.


Actionable Analysis News and Intelligence From Interviews with Leading Nationwide Experts

Analysis of nationwide clinical laboratory COVID-19 lab test reports

Redfield Defends Bypassing the CDC on Crucial COVID-19 Data

The National Healthcare Safety Network (NHSN) module was one of four pathways to reporting crucial COVID-19 data to HHS. The NHSN module was deactivated with the TeleTracking HHS Protect portal becoming the primary pathway for hospitals, hospital laboratories, and other healthcare facilities. The decision has met criticism.

Read More

Life After COVID: Positioning Your Lab for Success in a Post-Pandemic World

Now available for streaming: How does your lab begin to prepare itself to succeed in a post-pandemic world? Start your plan now to navigate the transition. Attend this complimentary webinar and hear the ways in which your lab’s current testing can create assets for the future, and how you can best position your lab for success in a post-pandemic environment by leveraging your diagnostic data as a strategic asset.

Read More »
COVID checklist

Achieving High Confidence Levels in the Quality and Accuracy of Your Clinical Lab’s Chosen COVID-19 Serology Tests

Now that your clinical laboratory has decided on which COVID-19 serology test it will buy and offer to physicians, patients, and employers with wellness screening programs, your lab team must succeed with the challenging process of validation. This is required—not just for your lab to meet CLIA requirements—but for your lab team to have high confidence that the COVID-19 serology test results are accurate, reproducible, and appropriate for use in patient care. Join us for this program as James O. Westgard and Sten Westgard, lead you through the process. 

Read More »


Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at


Robert L. Michel
President, Founder
The Dark Intelligence Group